LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,449 | -5.2% | 1,543 | +14.1% | 0.00% | – |
| Q2 2023 | $97,472 | -1.0% | 1,352 | +1.0% | 0.00% | – |
| Q1 2023 | $98,488 | +6.4% | 1,339 | -2.2% | 0.00% | – |
| Q4 2022 | $92,534 | -26.0% | 1,369 | -5.7% | 0.00% | – |
| Q3 2022 | $125,000 | -1.6% | 1,451 | +2.1% | 0.00% | – |
| Q2 2022 | $127,000 | -15.9% | 1,421 | +6.0% | 0.00% | – |
| Q1 2022 | $151,000 | -18.8% | 1,341 | +10.6% | 0.00% | – |
| Q4 2021 | $186,000 | +6.3% | 1,213 | -4.0% | 0.00% | – |
| Q3 2021 | $175,000 | 0.0% | 1,263 | -5.7% | 0.00% | – |
| Q2 2021 | $175,000 | -35.9% | 1,340 | -25.4% | 0.00% | -100.0% |
| Q1 2021 | $273,000 | +15.7% | 1,796 | -23.9% | 0.00% | 0.0% |
| Q4 2020 | $236,000 | -28.9% | 2,361 | -31.2% | 0.00% | 0.0% |
| Q3 2020 | $332,000 | -18.4% | 3,432 | -5.7% | 0.00% | 0.0% |
| Q2 2020 | $407,000 | +58.4% | 3,638 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $257,000 | – | 3,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |